Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia
- Conditions
- Gastric CancerNeoplasms
- Interventions
- Procedure: Standard of Care Procedure as described in ARM
- Registration Number
- NCT01471756
- Lead Sponsor
- Mayo Clinic
- Brief Summary
The investigators seek to compare two techniques of removing pre-cancerous lesions from the colon. The investigators also will compare two solutions used during the procedure to determine if either solution allows for an improved removal of the tumors.
- Detailed Description
The primary aim of the study is to compare the efficacy, efficiency and safety of two types of snares used in Endoscopic Mucosal Resection (EMR), a combined needle and snare unit (ISnare, US Endoscopy) versus an oval braided snare with spiral wire (Snaremaster, Olympus). The secondary aim is to explore whether EMR efficacy and efficiency is depended upon the injection solution used, saline versus Gonak (a solution containing HPMC, saline, and epinephrine) for EMR.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 66
- Sessile colorectal polyp
- laterally spreading lesions as defined by Paris Classification type II and > 1 cm or greater
- Those with ulcerated depressed lesions (Paris type III) or biopsy proven invasive carcinoma
- Inflammatory bowel disease patients
- Coagulopathy ( INR> 1.5) that cannot be corrected
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description Snaremaster braided snare with Gonak solution Standard of Care Procedure as described in ARM - Snaremaster braided snare with saline solution Standard of Care Procedure as described in ARM - iSnare with Gonak solution Standard of Care Procedure as described in ARM - iSnare with saline solution Standard of Care Procedure as described in ARM -
- Primary Outcome Measures
Name Time Method Efficacy of Two Devices used in EMR 1 year To explore the efficacy of two devices used in EMR (iSnare® system versus Snaremaster) as measured by the "Sydney Resection Quotient" (SRQ). SRQ is defined as "lesion size in mm divided by the number of pieces to resect" .
- Secondary Outcome Measures
Name Time Method Compare the Use of Two Injectates 1 year To compare the use of two injectates (saline versus HPMC mixture) with respect to efficacy as measured by the aforementioned SRQ.
Trial Locations
- Locations (1)
Mayo Clinic
🇺🇸Jacksonville, Florida, United States